Pemetrexed (brand name Alimta) is a chemotherapy drug manufactured and marketed by Eli Lilly and Company. Its indications are the treatment of pleural mesothelioma and non-small cell lung cancer.
This report contains market size and forecasts of Pemetrexed in global, including the following market information:
Global Pemetrexed Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pemetrexed Market Sales, 2017-2022, 2023-2028, (Units)
Global top five Pemetrexed companies in 2021 (%)
The global Pemetrexed market was valued at 1773.1 million in 2021 and is projected to reach US$ 1857.9 million by 2028, at a CAGR of 0.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
100mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pemetrexed include Eli Lilly, Abbott Laboratories, Cadila Healthcare, Eagle Pharmaceuticals and Stada Arzneimittel, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pemetrexed manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pemetrexed Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Pemetrexed Market Segment Percentages, by Type, 2021 (%)
100mg
500mg
Global Pemetrexed Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Pemetrexed Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Pemetrexed Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Pemetrexed Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pemetrexed revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pemetrexed revenues share in global market, 2021 (%)
Key companies Pemetrexed sales in global market, 2017-2022 (Estimated), (Units)
Key companies Pemetrexed sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eli Lilly
Abbott Laboratories
Cadila Healthcare
Eagle Pharmaceuticals
Stada Arzneimittel